After the Ranbaxy-Daiichi board meet, pharma major Ranbaxy has decided to re-constitute its board. The Managing Director and Chief Executive Officer, Malvinder Singh, will now move on as Chairman with immediate effect.
Indian pharma giant has customers in 125 countries and alliances in 49 countries.
http://www.ibnlive.com/news/ranbaxy-chief-quits-japanese-takeover-of-firm-final/93276-7.html
Ranbaxy-Daiichi Sankyo is still good despite the co's trouble with US laws.
http://www.ibnlive.com/news/ranbaxys-us-fda-case-may-hurt-other-indian-pharmas/73813-7.html
The Indian drug giant, Ranbaxy is a major maker of an AIDS generic drug.
http://www.ibnlive.com/news/us-fda-bans-dozens-of-ranbaxy-drugs/73728-7.html
Daiichi Sankyo to pump in Rs 10,000 crores to acquire stake in Ranbaxy.
http://www.ibnlive.com/news/daiichi-gets-green-signal-to-buy-into-ranbaxy/70490-7.html
It wants to know if FDA allowed Ranbaxy's faulty medicine deliberately.
http://www.ibnlive.com/news/us-cong-to-probe-fdas-ranbaxy-case/69021-7.html
India's largest pharma company is being investigated in the US for alleged fraud.
http://www.ibnlive.com/news/deal-with-daiichi-on-insists-ranbaxy-labs-chief/68981-7.html
Malvinder Singh says Daiichi Sankyo was aware of the US FDA issue before the deal was signed.
http://www.ibnlive.com/news/ranbaxy-allays-fears-over-daiichi-deal/68958-7.html
Ranbaxy strongly denied allegations and will file a response later on Monday.
http://www.ibnlive.com/news/us-fda-takes-ranbaxy-to-court-alleges-fraud/68838-7.html
India is emerging as an R&D base, challenging the West pharma giants.
http://www.ibnlive.com/news/emergency-pill-for-west-pharma-giant-indias-arrives/67029-7.html
Existing management to continue under CEO and MD, Malvinder Singh.
http://www.ibnlive.com/news/ranbaxy-sells-its-majority-stake-to-japans-daiichi/66998-7.html
 |
|
